UP!
| 2016-07-12 | Reiterated Rating | Royal Bank Of Canada | Buy | |
| 2016-07-12 | Reiterated Rating | Bank of America Corp. | Buy | |
| 2016-06-23 | Reiterated Rating | Leerink Swann | Buy | $53.00 |
| 2016-06-15 | Reiterated Rating | Jefferies Group | Buy | $43.00 |
| 2016-06-02 | Reiterated Rating | Chardan Capital | Buy | |
| 2016-05-14 | Reiterated Rating | Jefferies Group | Buy | |
| 2016-05-10 | Reiterated Rating | Cowen and Company | Buy | |
| 2016-05-06 | Reiterated Rating | Jefferies Group | Buy | $44.00 |
| 2016-05-05 | Initiated Coverage | Cowen and Company | Outperform | $45.00 |
| 2016-04-19 | Reiterated Rating | Jefferies Group | Buy | |
| 2016-04-16 | Reiterated Rating | Leerink Swann | Outperform | |
| 2016-04-08 | Reiterated Rating | Leerink Swann | Buy | $53.00 |
| 2016-03-31 | Reiterated Rating | JPMorgan Chase & Co. | Buy | |
| 2016-03-24 | Reiterated Rating | Oppenheimer | Hold | |
| 2016-03-24 | Reiterated Rating | Oppenheimer Holdings Inc. | Hold | |
| 2016-03-21 | Boost Price Target | Chardan Capital | Buy | $50.00 to $65.00 |
| 2016-02-18 | Lower Price Target | Jefferies Group | Buy | $50.00 to $44.00 |
| 2016-01-22 | Reiterated Rating | Jefferies Group | Buy | $50.00 |
| 2016-01-22 | Reiterated Rating | JPMorgan Chase & Co. | Overweight | $50.00 |
| 2015-12-22 | Reiterated Rating | Chardan Capital | Buy | $50.00 |
| 2015-12-08 | Boost Price Target | JPMorgan Chase & Co. | Overweight | $45.00 to $50.00 |
| 2015-11-16 | Boost Price Target | RBC Capital | Outperform | $46.00 to $48.00 |
| 2015-11-16 | Boost Price Target | Royal Bank Of Canada | Outperform | $46.00 to $48.00 |
| 2015-11-06 | Reiterated Rating | Piper Jaffray | Neutral | $28.00 to $31.00 |
| 2015-11-06 | Reiterated Rating | Piper Jaffray Cos. | Neutral | $28.00 to $31.00 |
| 2015-11-04 | Boost Price Target | Guggenheim | $42.00 to $45.00 | |
| 2015-11-04 | Initiated Coverage | Chardan Capital | Buy | $50.00 |
| 2015-09-01 | Reiterated Rating | RBC Capital | Buy | |
| 2015-08-31 | Reiterated Rating | Citigroup Inc. | Hold | |
| 2015-08-31 | Reiterated Rating | Leerink Swann | Outperform | $40.00 to $53.00 |
| 2015-08-31 | Reiterated Rating | Oppenheimer | Hold | |
| 2015-08-31 | Boost Price Target | RBC Capital | Outperform | $39.00 to $46.00 |
| 2015-08-29 | Reiterated Rating | JPMorgan Chase & Co. | Buy | $45.00 |
| 2015-08-28 | Upgrade | Jefferies Group | Hold to Buy | $29.00 to $43.00 |
| 2015-08-17 | Boost Price Target | Leerink Swann | Outperform | $35.00 to $40.00 |
| 2015-07-29 | Reiterated Rating | Guggenheim | Buy | $42.00 |
| 2015-07-10 | Reiterated Rating | Oppenheimer | Sector Perform | |
| 2015-07-06 | Upgrade | Mizuho | Neutral to Buy | $28.00 to $41.00 |
| 2015-07-02 | Reiterated Rating | RBC Capital | Buy | $39.00 |
| 2015-06-24 | Boost Price Target | Leerink Swann | Outperform | $33.00 to $35.00 |
| 2015-06-02 | Set Price Target | Guggenheim | Buy | $42.00 |
| 2015-05-09 | Reiterated Rating | RBC Capital | Outperform | $38.00 to $39.00 |
| 2015-05-06 | Boost Price Target | JPMorgan Chase & Co. | Overweight | $31.00 to $32.00 |
| 2015-05-06 | Lower Price Target | Leerink Swann | Outperform | $35.00 to $33.00 |
| 2015-04-16 | Set Price Target | Citigroup Inc. | Hold | $30.00 to $32.00 |
| 2015-04-10 | Lower Price Target | Mizuho | Neutral | $30.00 to $27.50 |
| 2015-03-27 | Initiated Coverage | Citigroup Inc. | Neutral | $30.00 |
| 2015-03-19 | Initiated Coverage | Mizuho | Neutral | $30.00 |
| 2015-01-26 | Boost Price Target | Citigroup Inc. | Neutral | $27.00 to $30.00 |
| 2015-01-21 | Upgrade | Leerink Swann | Market Perform to Outperform | $24.00 to $31.00 |
| 2014-11-20 | Upgrade | Credit Suisse | Neutral to Outperform | $27.00 to $33.00 |
| 2014-11-20 | Upgrade | Credit Suisse Group AG | Neutral to Outperform | $27.00 to $33.00 |
| 2014-10-28 | Reiterated Rating | Credit Suisse | Neutral | $24.00 to $27.00 |
| 2014-10-23 | Reiterated Rating | Citigroup Inc. | Neutral | $30.00 to $27.00 |
| 2014-10-23 | Lower Price Target | Bank of America | Buy to Neutral | $37.00 to $27.00 |
| 2014-10-23 | Lower Price Target | Bank of America Corp. | Buy to Neutral | $37.00 to $27.00 |
| 2014-10-10 | Reiterated Rating | Credit Suisse | Neutral | $28.00 to $26.00 |
| 2014-04-17 | Downgrade | Leerink Swann | Outperform to Market Perform | $30.00 to $27.00 |
| 2014-04-02 | Downgrade | Piper Jaffray | Overweight to Neutral | $41.00 to $29.00 |
| 2014-02-13 | Lower Price Target | RBC Capital | Outperform | $50.00 to $44.00 |
| 2014-02-13 | Downgrade | Credit Suisse | Outperform to Neutral | $45.00 to $35.00 |
| 2014-02-13 | Downgrade | Jefferies Group | Buy to Hold | $38.50 to $27.00 |
| 2013-12-05 | Boost Price Target | RBC Capital | Outperform | $41.00 to $50.00 |
| 2013-10-10 | Reiterated Rating | Leerink Swann | Outperform | $40.00 to $42.00 |
| 2013-02-21 | Reiterated | WallachBeth | Buy | $30 to $38 |
| 2012-11-20 | Initiated | Oppenheimer | Outperform | $35 |
| 2012-02-23 | Reiterated | RBC Capital Mkts | Outperform | $21 to $25 |
| 2011-08-26 | Reiterated | Argus | Buy | $25 to $20 |
| 2011-06-09 | Upgrade | Argus | Hold to Buy | $25 |
| 2010-10-07 | Downgrade | RBC Capital Mkts | Outperform to Sector Perform | $16 to $16 |
| 2010-08-04 | Upgrade | Wedbush | Underperform to Neutral | $9 to $14 |
| 2010-05-26 | Upgrade | RBC Capital Mkts | Sector Perform to Outperform | $10 |
| 2010-02-18 | Reiterated | Wedbush Morgan | Underperform | $11 to $10 |
| 2009-09-15 | Downgrade | Wedbush Morgan | Neutral to Underperform | $10 to $11 |
| 2009-07-30 | Downgrade | UBS | Buy to Neutral | |
| 2009-05-13 | Upgrade | Wedbush Morgan | Hold to Buy | |
| 2009-03-31 | Reiterated | RBC Capital Mkts | Sector Perform | $18 to $15 |
| 2009-02-19 | Reiterated | RBC Capital Mkts | Sector Perform | $25 to $18 |
| 2009-01-12 | Downgrade | Argus | Buy to Hold |
| 2016-07-12 | Reiterated Rating | Royal Bank Of Canada | Buy | |
| 2016-07-12 | Reiterated Rating | Bank of America Corp. | Buy | |
| 2016-06-23 | Reiterated Rating | Leerink Swann | Buy | $53.00 |
| 2016-06-15 | Reiterated Rating | Jefferies Group | Buy | $43.00 |
| 2016-06-02 | Reiterated Rating | Chardan Capital | Buy |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In MDCO 27 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| BlackRock Fund Advisors | 6.83M |
| BlackRock Institutional Trust Company, N.A. | 1.82M |
| RS INVESTMENT MANAGEMENT CO LLC | 1.20M |
| BlackRock Investment Management, LLC | 0.35M |
| TEACHERS ADVISORS INC | 0.26M |
| BlackRock Group LTD | 0.14M |
| TIAA CREF INVESTMENT MANAGEMENT LLC | 0.13M |
| MANAGED ACCOUNT ADVISORS LLC | 0.12M |
| Iguana Healthcare Management, LLC | 70000 |
| Adamant Biomedical Investments AG | 50000 |
| VERTEX ONE ASSET MANAGEMENT INC. | 42400 |
| TIAA CREF TRUST CO FSB/MO | 39457 |
| BLACKROCK ADVISORS LLC | 37079 |
| Signpost Capital Advisors, LP | 34423 |
| COWEN GROUP, INC. | 25100 |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| DENNER ALEXANDER J | 2.95% (1922000) | APRI / ARIA / BIIB / ENZN / MDCO / MSTX / VVUS / |
| ESHELMAN FREDRIC N | 1.73% (1128383) | FURX / MDCO / VRX / |
| MEANWELL CLIVE Chairman & CEO | 0.69% (452034) | MDCO / |
| HUGIN ROBERT J | 0.25% (163431) | CELG / DHR / MDCO / |
| KESSLER ARMIN M | 0.20% (130993) | MDCO / |
| SBLENDORIO GLENN President & CFO | 0.15% (99805) | FOLD / ICPT / MDCO / OPHT / |
| WYATT ELIZABETH H S | 0.09% (60633) | MDCO / |
| Cox Christopher T EVP & Chief Corp. Dev. Officer | 0.09% (59933) | DWCH / MDCO / |
| Spigelman Melvin K | 0.08% (53133) | MDCO / SGYP / |
| CROUSE WILLIAM | 0.08% (53133) | MDCO / |
| Furse Brent EVP, Chief Customer Officer | 0.06% (41044) | ANTH / MDCO / |
| Frazier Jeff EVP, Chief Human Strategy Ofcr | 0.05% (34350) | MDCO / |
| Heiman Cornelis EVP, Chief Innovation Officer | 0.05% (31457) | MDCO / |
| Savage Robert G. | 0.05% (31146) | IMNP / KBIO / MDCO / MWRX / |
| Antinori Paul Michael Sr. VP & General Counsel | 0.05% (31080) | MDCO / |
| Rodin Stephen M SVP and General Counsel | 0.04% (29199) | MDCO / |
| Shigeta Hiroaki | 0.04% (26784) | MDCO / MNOV / |
| Kelly John C. | 0.04% (24719) | BCR / MDCO / |
| O'Connor William Bernard Chief Accounting Officer | 0.03% (21882) | MDCO / |
| Kingsley Stuart A President & COO | 0.02% (11386) | BIIB / MDCO / PRTO / |
| Panayiotopoulos Paris | 0.01% (6452) | ARIA / MDCO / |
UM